Pharvaris BV is a clinical-stage biopharmaceutical company based in Leiden, the Netherlands, specializing in the development and commercialization of innovative therapies for rare diseases. The company is dedicated to addressing unmet medical needs, with a primary focus on treatments for hereditary angioedema, an orphan disease affecting patient populations worldwide. Pharvaris leverages its proprietary drug development platform to advance its pipeline, aiming to improve the quality of life for individuals suffering from these challenging conditions.